Harrow Ip, LLC

Novel Drug Solutions LLC

Eye Care Northwest, Pa

Imprimis Pharmaceuticals, Inc.

Pyp Car Northwest, Pa

Novel Drug Soultions LLC

Harrow Health, Inc.

John Scott Karolchyk

Mark L Baum

Richard Dilzer

Jeffrey T Liegner

Bernard Covalesky

John P Saharek

Dennis Elias Saadeh

Kallan Kuper

Kalian Peters

Kallan Peters

Jeffery T Liegner

William Wiley

Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.

Pharmaceutical ophthalmic compositions

Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as triamcinolone), at least one pharmaceutically acceptable excipient and a pharmaceutically acceptable carrier. Methods for fabricating the compositions and using them for intraocular injections are also described.

Pharmaceutical compositions for intraocular administration and methods for fabricating thereof

Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof

Methods and kits for improving tear production are described, along with topical pharmaceutical compositions. In certain instances, the composition comprises pentoxifylline and a pharmaceutically acceptable carrier. The compositions also may further comprise another active agent, such as an anti-bacterial agent, antiviral agent, antifungal agent, or immunosuppressant agent, and combinations thereof.

Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof

Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.

Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof

Methods and kits for improving tear production are described, along with topical pharmaceutical compositions. In certain instances the composition comprises pentoxifylline and a pharmaceutically acceptable carrier. The compositions also may further comprise another active agent, such as an anti-bacterial agent, antiviral agent, antifungal agent, or immunosuppressant agent, and combinations thereof.

Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic or burn-treating applications are also described.

Pharmaceutical compositions comprising gels and methods for fabricating thereof

Growing community of inventors

Lake Hopatcong, NJ, United States of America

John Scott Karolchyk